Orforglipron is an oral, non-peptide glucagon-like peptide-1 receptor agonist under clinical investigation for type 2 diabetes. It is a complex polycyclic compound with multiple aromatic rings and heterocycles, used as an active pharmaceutical ingredient in research.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2212020-52-3
Orforglipron hemicalcium hydrate
active pharmaceutical ingredient
Tyr-somatostatin (177-191)
active pharmaceutical ingredient
Olanzapine pamoate
active pharmaceutical ingredient
25-Hydroxy-7-dehydrocholesterol
vitamin D metabolite
Deksketoprofen
active pharmaceutical ingredient
3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one
USUWIEBBBWHKNI-KHIFEHGGSA-N
C[C@H]1C[C@]1(C2=NOC(=O)N2)N3C4=C(C=C(C=C4)[C@H]5CCOC(C5)(C)C)C=C3C(=O)N6CCC7=NN(C(=C7[C@@H]6C)N8C=CN(C8=O)C9=C(C1=C(C=C9)N(N=C1)C)F)C1=CC(=C(C(=C1)C)F)C